Medicina Nuclear

Alarcon L., Lopez-Mora D., Fernandez A., Carrio I., Camacho V. (2020) Use of PET/CT with 18F-FDG in the diagnosis of paraneoplastic limbic encephalitis Utilidad de la PET/TC con 18F-FDG en el diagnóstico de la encefalitis límbica paraneoplásica. REV ESP MED NUCL IMA, 39 (3), 173-174.

IF: 1,359

Ballester Vazquez E., Perez Garcia J.I., Lopez Mora D.A., Galan Martinez C., Pareja Nieto E., Clos Enrriquez M., Gonzalez Lopez J.A., Moral Duarte A. (2020) Identification of Occult Adenomas in Primary Hyperparathyroidism With 18F-fluorocholine PET/CT Identificación de adenomas ocultos en hiperparatiroidismo primario con PET-TC 18F-fluorocolina. CIR ESPAN, 98 (7), 395-402.

IF: 1,653

Carrio I., Flotats A. (2020) Liquid biopsies and molecular imaging: friends or foes?. CLIN TRANSL IMAGING, 8 (1), 47-50.

IF: 2,750

Carrió I, Herrmann K. A Conversation Between Ignasi Carrió and Ken Herrmann. J NUCL MED. 2020 May;61(5):638-640.

IF: 10,057

De Cuypere M., Lovinfosse P., Goffin F., Gennigens C., Rovira R., Duch J., Fastrez M., Gebhart G., Squifflet J.L., Luyckx M., Charaf G., Crener K., Buxant F., Bucella D., Jouret M., Hustinx R., Kridelka F. (2020) Added value of para-aortic surgical staging compared to 18F-FDG PET/CT on the external beam radiation field for patients with locally advanced cervical cancer: An ONCO-GF study. EJSO-EUR J SURG ONC, 46 (5), 883-887.

IF: 4,424

De Cuypere M., Lovinfosse P., Gennigens C., Hermesse J., Rovira R., Duch J., Goffin F., Hustinx R., Kridelka F. (2020) Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer. INT J GYNECOL CANCER, 30 (11), 1705-1712.

IF: 3,437

Fortea J., Vilaplana E., Carmona-Iragui M., Benejam B., Videla L., Barroeta I., Fernandez S., Altuna M., Pegueroles J., Montal V., Valldeneu S., Gimenez S., Gonzalez-Ortiz S., Munoz L., Estelles T., Illan-Gala I., Belbin O., Camacho V., Wilson L.R., Annus T., Osorio R.S., Videla S., Lehmann S., Holland A.J., Alcolea D., Clarimon J., Zaman S.H., Blesa R., Lleo A. (2020) Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. LANCET, 395 (10242), 1988-1997.

IF: 79,321

Freudenberg LS, Paez D, Giammarile F, Cerci JJ, Modiselle M, Pascual TNB, El-Haj N, Orellana P, Carrio I, Fanti S, Matushita CS, Pynda Y, Herrmann K. Global Impact of COVID-19 on Nuclear Medicine Departments: An International Survey in April 2020. J NUCL MED. 2020; 61(9):1278-1283.

IF: 10,057

López-Mora DA, Carrió I Advances And New Indications of PET/CT scan. MED CLIN (BARC). 2020 Jun 30:S0025-7753(20)30284-0. doi: 10.1016/j.medcli.2020.04.019. Online ahead of print. PMID: 32620354.

IF: 1,725

Lopez-Mora D.A., Flotats A., Fernandez A., Sizova M., Camacho V., Carrio I. (2020) Striking neurologic 18F-FDG PET/CT pattern in Devic’s disease (neuromyelitis optica spectrum disorder). EUR J NUCL MED MOL I, 47 (2), 511-512.

IF: 9,236

Lopez Mora DA, Flotats A, Fuentes-Ocampo F, Carrio I. Reported differences between Digital and Analog PET/CT studies. J NUCL MED. 2020 May 1:jnumed.120.244608. doi: 10.2967/jnumed.120.244608. Online ahead of print. PMID: 32358090.

IF: 10,057

Lopez-Mora D.A., Sizova M., Estorch M., Flotats A., Camacho V., Fernandez A., Abouzian S., Fuentes-Ocampo F., Garcia J.I.P., Ballesteros A.I.C., Duch J., Domenech A., Duarte A.M., Carrio I. (2020) Superior performance of 18F-fluorocholine digital PET/CT in the detection of parathyroid adenomas. EUR J NUCL MED MOL I, 47 (3), 572-578.

IF: 9,236

Lopez-Mora D.A., Fernandez Leon A., Lleo A., Blesa R., Camacho V. (2020) The Added Value of Tau-PET in the Assessment of Progressive Supranuclear Palsy. CLIN NUCL MED, 45 (5), E239-E240.

IF: 7,794

Lopez-Mora D.A., Fernandez A., Duch J., Carrio I. (2020) Follow-up 18F-FDG PET/CT in an oncological asymptomatic COVID-19 patient 18F-FDG PET/TC de seguimiento en un paciente oncológico portador asintomático de COVID-19. REV ESP MED NUCL IMA, (), -.

IF: 1,359

Marin-Lahoz J., Sampedro F., Horta-Barba A., Martinez-Horta S., Aracil-Bolanos I., Camacho V., Bejr-kasem H., Pascual-Sedano B., Perez-Perez J., Gironell A., Pagonabarraga J., Carrio I., Kulisevsky J. (2020) Preservation of brain metabolism in recently diagnosed Parkinson’s impulse control disorders. EUR J NUCL MED MOL I, 47 (9), 2165-2174.

IF: 9,236

Ninerola-Baizan A., Aguiar P., Cabrera-Martin M.N., Vigil C., Gomez-Grande A., Lorenzo C., Rubi S., Sopena P., Camacho V. (2020) Relevance of quantification in brain PET studies with 18F-FDG Relevancia de la cuantificación en los estudios PET cerebrales con 18F-FDG. REV ESP MED NUCL IMA, 39 (3), 184-192.

IF: 1,359

Roldan A., Portella M.J., Sampedro F., Alonso-Solis A., Sarro S., Rabella M., Grasa E.M., Alvarez E., Rodriguez R., Camacho V., Fernandez-Leon A., Fuentes F., Perez-Blanco J., Perez V., Mckenna P., Pomarol-Clotet E., Corripio I. (2020) Brain metabolic changes in patients with treatment resistant schizophrenia treated with deep brain stimulation: A series of cases. J PSYCHIATR RES, 127 (), 57-61.

IF: 4,791

Skali H, Murthy VL, Paez D, Choi EM, Keng FYJ, Iain MA, Al-Mallah M, Campisi R, Bateman TM, Carrio I, Beanlands R, Calnon DA, Dilsizian V, Dondi M, Gimelli A, Pagnanelli R, Polk DM, Soman P, Einstein AJ, Dorbala S, Thompson RC. Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI. J NUCL MED. 2020; 61/10):1534-1539.

IF: 10,057

Skali H, Murthy VL, Paez D, Choi EM, Keng FYJ, Iain MA, Al-Mallah M, Campisi R, Bateman TM, Carrio I, Beanlands R, Calnon DA, Dilsizian V, Dondi M, Gimelli A, Pagnanelli R, Polk DM, Soman P, Einstein AJ, Dorbala S, Thompson RC. Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI: Endorsed by the Infectious Diseases Society of America. J NUCL CARDIOL. 2020;27(8):1855-1862.

IF: 5,952